Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Cytokine signaling mediated by the JAK-STAT pathway plays essential roles in differentiation, maturation, proliferation and apoptosis of a various types of cells. Suppressor of cytokine signaling (SOCS) proteins are negative feedback regulators of the JAK-STAT signaling pathway. SOCS1 and SOCS3 are potent inhibitors of JAKs and can play pivotal roles in inflammation, as well as in the development and progression of cancers []. All SOCS share a central SH2 domain and a C-terminal SOCS box, but only SOCS1 and SOCS3 possess a kinase inhibitory region immediately upstream of the central SH2 [].SOCS1 plays a key role in the negative regulation of interferon-gamma signaling and in T cell differentiation [, , ]. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Takahashi R |
Year: |
2011 |
Journal: |
J Exp Med |
Title: |
SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production. |
Volume: |
208 |
Issue: |
10 |
Pages: |
2055-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jamieson E |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
Socs1 deficiency enhances hepatic insulin signaling. |
Volume: |
280 |
Issue: |
36 |
Pages: |
31516-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marine JC |
Year: |
1999 |
Journal: |
Cell |
Title: |
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. |
Volume: |
98 |
Issue: |
5 |
Pages: |
609-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu T |
Year: |
2012 |
Journal: |
Bone |
Title: |
miR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression. |
Volume: |
51 |
Issue: |
3 |
Pages: |
498-505 |
|
•
•
•
•
•
|
Publication |
First Author: |
Calabrese V |
Year: |
2009 |
Journal: |
Mol Cell |
Title: |
SOCS1 links cytokine signaling to p53 and senescence. |
Volume: |
36 |
Issue: |
5 |
Pages: |
754-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshida T |
Year: |
2004 |
Journal: |
J Exp Med |
Title: |
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. |
Volume: |
199 |
Issue: |
12 |
Pages: |
1701-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Larsen L |
Year: |
2002 |
Journal: |
APMIS |
Title: |
Suppressors of cytokine signalling: SOCS. |
Volume: |
110 |
Issue: |
12 |
Pages: |
833-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feng ZP |
Year: |
2012 |
Journal: |
Proteins |
Title: |
The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5. |
Volume: |
80 |
Issue: |
3 |
Pages: |
946-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inagaki-Ohara K |
Year: |
2013 |
Journal: |
JAKSTAT |
Title: |
SOCS, inflammation, and cancer. |
Volume: |
2 |
Issue: |
3 |
Pages: |
e24053 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2012 |
Journal: |
FEBS Lett |
Title: |
Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. |
Volume: |
586 |
Issue: |
19 |
Pages: |
3255-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krebs DL |
Year: |
2001 |
Journal: |
Stem Cells |
Title: |
SOCS proteins: negative regulators of cytokine signaling. |
Volume: |
19 |
Issue: |
5 |
Pages: |
378-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piñeros Alvarez AR |
Year: |
2017 |
Journal: |
JCI Insight |
Title: |
SOCS1 is a negative regulator of metabolic reprogramming during sepsis. |
Volume: |
2 |
Issue: |
13 |
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
212
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Qayum AA |
Year: |
2016 |
Journal: |
J Immunol |
Title: |
IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function. |
Volume: |
196 |
Issue: |
11 |
Pages: |
4457-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rao R |
Year: |
2014 |
Journal: |
Infect Immun |
Title: |
Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury. |
Volume: |
82 |
Issue: |
7 |
Pages: |
2971-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ushiki T |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. |
Volume: |
11 |
Issue: |
9 |
Pages: |
e0162111 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chinen T |
Year: |
2011 |
Journal: |
Nat Commun |
Title: |
Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. |
Volume: |
2 |
|
Pages: |
190 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hashimoto M |
Year: |
2011 |
Journal: |
Int Immunol |
Title: |
SOCS1 regulates type I/type II NKT cell balance by regulating IFNgamma signaling. |
Volume: |
23 |
Issue: |
3 |
Pages: |
165-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hashimoto M |
Year: |
2009 |
Journal: |
Cancer Sci |
Title: |
Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. |
Volume: |
100 |
Issue: |
4 |
Pages: |
730-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khan MGM |
Year: |
2023 |
Journal: |
Cancers (Basel) |
Title: |
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation. |
Volume: |
15 |
Issue: |
3 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Rodriguez GM |
Year: |
2013 |
Journal: |
J Invest Dermatol |
Title: |
SOCS1 prevents potentially skin-reactive cytotoxic T lymphocytes from gaining the ability to cause inflammatory lesions. |
Volume: |
133 |
Issue: |
8 |
Pages: |
2013-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Demirel Ö |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment. |
Volume: |
12 |
Issue: |
7 |
Pages: |
e0180401 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blumer T |
Year: |
2017 |
Journal: |
J Biol Chem |
Title: |
SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression in vivo. |
Volume: |
292 |
Issue: |
43 |
Pages: |
17928-17938 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karki P |
Year: |
2021 |
Journal: |
FASEB J |
Title: |
Microtubule-dependent mechanism of anti-inflammatory effect of SOCS1 in endothelial dysfunction and lung injury. |
Volume: |
35 |
Issue: |
4 |
Pages: |
e21388 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du J |
Year: |
2020 |
Journal: |
Dev Cell |
Title: |
N6-Adenosine Methylation of Socs1 mRNA Is Required to Sustain the Negative Feedback Control of Macrophage Activation. |
Volume: |
55 |
Issue: |
6 |
Pages: |
737-753.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coelho DR |
Year: |
2023 |
Journal: |
iScience |
Title: |
SOCS1 regulates a subset of NFκB-target genes through direct chromatin binding and defines macrophage functional phenotypes. |
Volume: |
26 |
Issue: |
4 |
Pages: |
106442 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lindeman GJ |
Year: |
2001 |
Journal: |
Genes Dev |
Title: |
SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. |
Volume: |
15 |
Issue: |
13 |
Pages: |
1631-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takahashi R |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions. |
Volume: |
199 |
Issue: |
1 |
Pages: |
149-158 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alice AF |
Year: |
2018 |
Journal: |
J Immunol |
Title: |
Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity. |
Volume: |
200 |
Issue: |
1 |
Pages: |
177-185 |
|
•
•
•
•
•
|
Publication |
First Author: |
Serezani CH |
Year: |
2011 |
Journal: |
J Clin Invest |
Title: |
Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. |
Volume: |
121 |
Issue: |
2 |
Pages: |
671-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu CR |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
SOCS1 regulates CCR7 expression and migration of CD4+ T cells into peripheral tissues. |
Volume: |
181 |
Issue: |
2 |
Pages: |
1190-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu LF |
Year: |
2009 |
Journal: |
Immunity |
Title: |
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. |
Volume: |
30 |
Issue: |
1 |
Pages: |
80-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kandhi R |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis. |
Volume: |
14 |
|
Pages: |
1259246 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sachithanandan N |
Year: |
2011 |
Journal: |
Diabetes |
Title: |
Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. |
Volume: |
60 |
Issue: |
8 |
Pages: |
2023-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alexander WS |
Year: |
1999 |
Journal: |
Cell |
Title: |
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. |
Volume: |
98 |
Issue: |
5 |
Pages: |
597-608 |
|
•
•
•
•
•
|
Publication |
First Author: |
Evel-Kabler K |
Year: |
2006 |
Journal: |
J Clin Invest |
Title: |
SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. |
Volume: |
116 |
Issue: |
1 |
Pages: |
90-100 |
|
•
•
•
•
•
|
Publication |
First Author: |
Opazo-Ríos L |
Year: |
2020 |
Journal: |
BMJ Open Diabetes Res Care |
Title: |
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes. |
Volume: |
8 |
Issue: |
1 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Yu CR |
Year: |
2011 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. |
Volume: |
52 |
Issue: |
9 |
Pages: |
6978-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sutherland APR |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
IL-21 regulates SOCS1 expression in autoreactive CD8+ T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic mice. |
Volume: |
9 |
Issue: |
1 |
Pages: |
15302 |
|
•
•
•
•
•
|
Publication |
First Author: |
Starr R |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo. |
Volume: |
183 |
Issue: |
7 |
Pages: |
4537-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Catlett IM |
Year: |
2005 |
Journal: |
Nat Immunol |
Title: |
Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells. |
Volume: |
6 |
Issue: |
7 |
Pages: |
715-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kinjyo I |
Year: |
2002 |
Journal: |
Immunity |
Title: |
SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. |
Volume: |
17 |
Issue: |
5 |
Pages: |
583-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stevenson NJ |
Year: |
2010 |
Journal: |
FEBS Lett |
Title: |
Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11. |
Volume: |
584 |
Issue: |
21 |
Pages: |
4469-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanada T |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. |
Volume: |
276 |
Issue: |
44 |
Pages: |
40746-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bullen DV |
Year: |
2003 |
Journal: |
Parasite Immunol |
Title: |
The lack of suppressor of cytokine signalling-1 (SOCS1) protects mice from the development of cerebral malaria caused by Plasmodium berghei ANKA. |
Volume: |
25 |
Issue: |
3 |
Pages: |
113-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanada T |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. |
Volume: |
174 |
Issue: |
7 |
Pages: |
4325-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ilangumaran S |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Suppressor of cytokine signaling 1 regulates an endogenous inhibitor of a mast cell protease. |
Volume: |
278 |
Issue: |
43 |
Pages: |
41871-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inagaki-Ohara K |
Year: |
2006 |
Journal: |
Gut |
Title: |
Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. |
Volume: |
55 |
Issue: |
2 |
Pages: |
212-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Collins EL |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
Inhibition of SOCS1-/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis. |
Volume: |
187 |
Issue: |
5 |
Pages: |
2666-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang P |
Year: |
2019 |
Journal: |
Yonsei Med J |
Title: |
Inhibition of miRNA-222-3p Relieves Staphylococcal Enterotoxin B-Induced Liver Inflammatory Injury by Upregulating Suppressors of Cytokine Signaling 1. |
Volume: |
60 |
Issue: |
11 |
Pages: |
1093-1102 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bullen DV |
Year: |
2001 |
Journal: |
Immunology |
Title: |
Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. |
Volume: |
104 |
Issue: |
1 |
Pages: |
92-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fujimoto A |
Year: |
2011 |
Journal: |
Mol Immunol |
Title: |
Involvement of suppressor of cytokine signaling-1 in globular adiponectin-induced granulocyte colony-stimulating factor in RAW 264 cell. |
Volume: |
48 |
Issue: |
15-16 |
Pages: |
2052-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanada T |
Year: |
2003 |
Journal: |
Immunity |
Title: |
Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. |
Volume: |
19 |
Issue: |
3 |
Pages: |
437-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Choi HI |
Year: |
2013 |
Journal: |
Free Radic Biol Med |
Title: |
Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway. |
Volume: |
65 |
|
Pages: |
270-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chong MM |
Year: |
2005 |
Journal: |
Blood |
Title: |
Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. |
Volume: |
106 |
Issue: |
5 |
Pages: |
1668-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mafanda EK |
Year: |
2019 |
Journal: |
Cytokine |
Title: |
Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. |
Volume: |
124 |
|
Pages: |
154501 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo Y |
Year: |
2022 |
Journal: |
Front Oncol |
Title: |
In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1. |
Volume: |
12 |
|
Pages: |
1031052 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao D |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
H3K4me3 Demethylase Kdm5a Is Required for NK Cell Activation by Associating with p50 to Suppress SOCS1. |
Volume: |
15 |
Issue: |
2 |
Pages: |
288-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Galic S |
Year: |
2014 |
Journal: |
Biochem J |
Title: |
Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. |
Volume: |
461 |
Issue: |
2 |
Pages: |
177-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsukada J |
Year: |
2005 |
Journal: |
Int Immunol |
Title: |
The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8alpha+ dendritic cell subset. |
Volume: |
17 |
Issue: |
9 |
Pages: |
1167-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ilangumaran S |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. |
Volume: |
171 |
Issue: |
5 |
Pages: |
2435-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tanaka K |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. |
Volume: |
180 |
Issue: |
6 |
Pages: |
3746-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Woodward EA |
Year: |
2010 |
Journal: |
Immunology |
Title: |
The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1). |
Volume: |
131 |
Issue: |
1 |
Pages: |
118-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Haffner MC |
Year: |
2008 |
Journal: |
J Biol Chem |
Title: |
Interaction and functional interference of glucocorticoid receptor and SOCS1. |
Volume: |
283 |
Issue: |
32 |
Pages: |
22089-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Balabanov R |
Year: |
2006 |
Journal: |
J Neurosci |
Title: |
Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. |
Volume: |
26 |
Issue: |
19 |
Pages: |
5143-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saba I |
Year: |
2011 |
Journal: |
Blood |
Title: |
IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. |
Volume: |
117 |
Issue: |
12 |
Pages: |
3370-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fenner JE |
Year: |
2006 |
Journal: |
Nat Immunol |
Title: |
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. |
Volume: |
7 |
Issue: |
1 |
Pages: |
33-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Uto-Konomi A |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines. |
Volume: |
7 |
Issue: |
7 |
Pages: |
e40343 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. |
Volume: |
185 |
Issue: |
10 |
Pages: |
6226-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diao Y |
Year: |
2009 |
Journal: |
Mol Cell Biol |
Title: |
SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. |
Volume: |
29 |
Issue: |
18 |
Pages: |
5084-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chinen T |
Year: |
2006 |
Journal: |
Gastroenterology |
Title: |
Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. |
Volume: |
130 |
Issue: |
2 |
Pages: |
373-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukuyama S |
Year: |
2009 |
Journal: |
Am J Respir Crit Care Med |
Title: |
Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. |
Volume: |
179 |
Issue: |
11 |
Pages: |
992-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Croom HA |
Year: |
2008 |
Journal: |
Mol Immunol |
Title: |
Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3. |
Volume: |
45 |
Issue: |
10 |
Pages: |
2888-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ramanathan S |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens. |
Volume: |
185 |
Issue: |
1 |
Pages: |
357-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zimmerer JM |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. |
Volume: |
178 |
Issue: |
8 |
Pages: |
4832-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ilangumaran S |
Year: |
2003 |
Journal: |
Blood |
Title: |
Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. |
Volume: |
102 |
Issue: |
12 |
Pages: |
4115-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Srivastava V |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection. |
Volume: |
284 |
Issue: |
38 |
Pages: |
25532-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yeganeh M |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver. |
Volume: |
35 |
Issue: |
32 |
Pages: |
4200-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohishi M |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines. |
Volume: |
174 |
Issue: |
5 |
Pages: |
3024-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alston CI |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3. |
Volume: |
12 |
Issue: |
2 |
Pages: |
e0171812 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carow B |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner. |
Volume: |
286 |
Issue: |
30 |
Pages: |
26873-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sharma J |
Year: |
2021 |
Journal: |
Sci Rep |
Title: |
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model. |
Volume: |
11 |
Issue: |
1 |
Pages: |
6354 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun K |
Year: |
2014 |
Journal: |
PLoS Pathog |
Title: |
Expression of suppressor of cytokine signaling 1 (SOCS1) impairs viral clearance and exacerbates lung injury during influenza infection. |
Volume: |
10 |
Issue: |
12 |
Pages: |
e1004560 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanada T |
Year: |
2006 |
Journal: |
J Exp Med |
Title: |
IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. |
Volume: |
203 |
Issue: |
6 |
Pages: |
1391-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bullen DV |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Persistence of lesions in suppressor of cytokine signaling-1-deficient mice infected with Leishmania major. |
Volume: |
170 |
Issue: |
8 |
Pages: |
4267-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gingras S |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. |
Volume: |
279 |
Issue: |
52 |
Pages: |
54702-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Batchu SN |
Year: |
2015 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
Axl modulates immune activation of smooth muscle cells in vein graft remodeling. |
Volume: |
309 |
Issue: |
6 |
Pages: |
H1048-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bouamar H |
Year: |
2015 |
Journal: |
Mol Cell Biol |
Title: |
MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1. |
Volume: |
35 |
Issue: |
8 |
Pages: |
1329-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nold-Petry CA |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling. |
Volume: |
284 |
Issue: |
38 |
Pages: |
25900-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rothlin CV |
Year: |
2007 |
Journal: |
Cell |
Title: |
TAM receptors are pleiotropic inhibitors of the innate immune response. |
Volume: |
131 |
Issue: |
6 |
Pages: |
1124-36 |
|
•
•
•
•
•
|